Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Blood Cell Storage, Inc.
Novel New Approach to Monitor pH in Closed Incubator for In Vitro Fertilization (IVF)
BOSTON, Oct. 14, 2013 /PRNewswire/ -- Blood Cell Storage, Inc. (BCSI), a leading medical device provider based in Seattle, WA announced today during the American Society for Reproductive Medicine (ASRM) annual event in Boston, that their newest product, SAFE Sens IVM (in vessel monitoring), has begun shipping to customers and is generally available. SAFE Sens IVM, is a pH monitoring system used by embryologists and clinical staff, that reports, trends and archives pH measurements without disturbing culture conditions within a closed incubator.
About SAFE Sens™
The SAFE Sens (Sterile, Automated Fluoroscopic Evaluation) is an optical fluorescent measurement device. It is used in combination with a disposable sensor, to accurately and reliably measure the pH of small volumes of fluids such as the media used in IVF. The sensor contains a proprietary fluorescent dye that is pH sensitive. Each lot of sterile sensors last six (6) days and have a certification pHID supplied by the manufacturer. This pHID code is used to tell the SAFE Sens device how to specifically interpret the fluorescent measurement for each lot of sensors into a pH value.
Since it is important to make sure that over time the SAFE Sens IVM continues to perform the optical fluorescent measurements properly, the SAFE Sens system uses a Quality Control Standard, qc1. The qc1 device has a known fluorescence value allowing the SAFE Sens device to compare and adjust itself to the known value. When the value is outside of the acceptable bounds the SAFE Sens IVM will alert the user and automatically make an adjustment to bring the system back into control.
"Our early customers are validating that pH monitoring and control is key," said Russ Aldrich, CEO, BCSI. "We're hearing over and over that pH control is a requirement for achieving better ART outcomes."
The SAFE technology is covered by multiple issued and pending US and International equivalent patents. Visit www.safesens.com to learn more about SAFE Sens.
Blood Cell Storage, Inc. (BCSI) www.bloodcellstorage.com is a privately held international medical device company based in Seattle, Washington, with European operations located in The Netherlands.
BCSI has created two unique product lines that benefit patients, clinicians, researchers, pathologists and doctors using patented technologies. Our fluorescent dyes, micro-fluidics, Nucleic Acid Extraction capabilities and automated systems reduce healthcare costs while improving patient outcomes. www.safesens.com
SAFE Sens is a trademark of BCSI. All other names or product names mentioned in this release are trademarks or registered trademarks of their respective companies.
SAFE Systems Product Manager
©2012 PR Newswire. All Rights Reserved.